Figure 4.
The lifespan of oxaloacetate-treated SOD1G93A mice. (A) The median end-stage age of oxaloacetate treatment of SOD1G93A mice from the presymptomatic stage (60 days old, red) was 158.5, which was the same as the control group of non-injected SOD1G93A mice (black, p = 0.3717, log-rank test). (B) The median end-stage age of oxaloacetate treatment from the symptomatic stage (110 days old, blue) was 165 days. This median age was not statistically different from the control group (p = 0.051, log-rank test). The graphs show Kaplan–Meier curves with n = 12 mice per group. These graphs contain mice that are identical to the mice in Fig. 1.